ResearcherInsermNo recent work listed
Philippe B Ruszniewski
Matched on OpenAlex author ID A5113985918. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2012: 2 papers · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers
Papers 7
- In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.24084↗
- Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process. Co-author DOI 10.18632/oncotarget.25458↗
- Epidemiology of pancreatic cancer in France: descriptive study from the French national hospital database. Last author DOI 10.1097/meg.0000000000000901↗
- High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis. Co-author DOI 10.1111/his.12691↗
- EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins. Co-author DOI 10.1136/jclinpath-2013-201662↗
- Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples. Co-author DOI 10.1016/j.pan.2011.12.003↗
- Biological and prognostic relevance of mitogen-activated protein kinases in pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e318238379d↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pascal R. Hammel · 6 shared papers, 2012–2018 · strength 0.29
- Paper Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process. DOI 10.18632/oncotarget.25458↗
- Paper Epidemiology of pancreatic cancer in France: descriptive study from the French national hospital database. DOI 10.1097/meg.0000000000000901↗
- Paper EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins. DOI 10.1136/jclinpath-2013-201662↗
- Anne Couvelard · 4 shared papers, 2012–2018 · strength 0.19
- Paper In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreat… DOI 10.18632/oncotarget.24084↗
- Paper EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins. DOI 10.1136/jclinpath-2013-201662↗
- Paper High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correl… DOI 10.1111/his.12691↗
- Alain Sauvanet · 4 shared papers, 2012–2018 · strength 0.19
- Paper In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreat… DOI 10.18632/oncotarget.24084↗
- Paper EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins. DOI 10.1136/jclinpath-2013-201662↗
- Paper High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correl… DOI 10.1111/his.12691↗
- Vinciane Rebours · 3 shared papers, 2012–2018 · strength 0.17
- Paper Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process. DOI 10.18632/oncotarget.25458↗
- Paper In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreat… DOI 10.18632/oncotarget.24084↗
- Paper Biological and prognostic relevance of mitogen-activated protein kinases in pancreatic adenocarcinoma. DOI 10.1097/mpa.0b013e318238379d↗
- Jerome F. Cros · 2 shared papers, 2015–2018 · strength 0.12
- Paper In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreat… DOI 10.18632/oncotarget.24084↗
- Paper High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correl… DOI 10.1111/his.12691↗
- Valérie Paradis · 2 shared papers, 2015–2018 · strength 0.12
- Paper In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreat… DOI 10.18632/oncotarget.24084↗
- Paper High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correl… DOI 10.1111/his.12691↗
- Adriana Handra‐Luca · 2 shared papers, 2012–2014 · strength 0.08
- Dorothée Faille · 1 shared paper, 2018 · strength 0.07
- Stéphanie Dayot · 1 shared paper, 2018 · strength 0.07
- Thierry Voisin · 1 shared paper, 2018 · strength 0.07
- Alain Couvineau · 1 shared paper, 2018 · strength 0.07
- Frédérique Maire · 1 shared paper, 2017 · strength 0.07
- Olivia Hentic · 1 shared paper, 2017 · strength 0.07
- Annemilaï Tijeras‐Raballand · 1 shared paper, 2015 · strength 0.04
- Cindy Neuzillet · 1 shared paper, 2015 · strength 0.04
- Louis de Mestier · 1 shared paper, 2015 · strength 0.04
- Éric Raymond · 1 shared paper, 2015 · strength 0.04
- Jean‐Baptiste Bachet · 1 shared paper, 2015 · strength 0.04
- Fabrice Muscari · 1 shared paper, 2012 · strength 0.03
- Louis Buscail · 1 shared paper, 2012 · strength 0.03
- Pierre Cordelier · 1 shared paper, 2012 · strength 0.03
- Barbara Bournet · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.